1. Introduction {#s0005}
===============

Taste signals and nutrient stimuli sensed by the gastrointestinal (GI) tract are transmitted to the central nervous system, including the nucleus of the solitary tract and hypothalamus, via afferent neurons and humoral mediators, thereby controlling feeding behavior and energy homeostasis. This system is referred to as the gut-brain axis ([@bb0045], [@bb0055]). This information is subsequently conveyed from the brain to peripheral tissues via efferent sympathetic and parasympathetic nerves including preganglionic sympathetic splanchnic input to the adrenal glands. For example, gut incretins such as glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1), which are released from the intestinal enteroendocrine cells in response to nutrient ingestion, potentiate glucose-stimulated insulin secretion (GSIS) from pancreatic β-cells ([@bb0255]). GLP-1 also activates the GLP-1 receptors expressed on vagal afferent nerve terminals in the portal vein and in the brain across the blood-brain barrier, which is involved in the regulation of appetite ([@bb0105], [@bb0110], [@bb0235]). Gavage of agonists for bitter taste receptor increases food intake via the secretion of ghrelin, a hormone that potentiates hunger sensation ([@bb0100]).

The *Skn-1* (also known as *Pou2f3*) gene, which encodes the POU homeodomain transcription factor, was originally identified as a regulator of the differentiation of epidermal keratinocytes ([@bb0005], [@bb0010]). We previously reported that *Skn-1a* is expressed in sweet, umami (savory), and bitter-sensing taste cells, which are referred to as type II taste cells ([@bb0140]). Type II taste cells are completely eliminated in *Skn-1* knockout (KO) mice, resulting in loss of electrophysiological and behavioral responses to sweet, umami, and bitter tastes. Thus, *Skn-1a* is critical for generating type II taste cells. *Skn-1a* is also required for the generation of *Trpm5*-expressing solitary chemosensory cells (SCCs) in the nasal respiratory epithelium and microvillous cells in the main olfactory epithelium ([@bb0170], [@bb0260]). *Skn-1a* is expressed in several tissues including the stomach, but not in the brain ([@bb0280]).

There are four major cell types in the small intestine: enterocytes and Goblet, Paneth, and enteroendocrine cells ([@bb0240]). In addition to these cell types, brush cells (also referred to as tuft cells or caveolated cells) constitute a minor fraction (0.4%) of the adult mouse intestinal epithelium ([@bb0075]). Brush cells are supposed to be chemosensory cells ([@bb0275]) and express transient receptor potential melastatin 5 (*Trpm5*), Doublecortin-like kinase 1 (*Dclk1*), and choline acetyltransferase ([@bb0025], [@bb0065], [@bb0070], [@bb0195], [@bb0200]). The mechanisms of differentiation and the function of brush cells remain elusive.

In the present study, we found that *Skn-1a* regulates differentiation of *Trpm5*-expressing brush cells in the GI tract. *Skn-1* KO mice exhibited reduced body weight with lower body fat than wild-type (WT) littermates. Despite unaltered food intake, *Skn-1* KO mice exhibited increased energy expenditure, caused by augmented catecholamine secretion. Our work raises the concept that taste cells receiving sweet, bitter, and umami tastes as well as brush cells receiving food-borne chemicals are involved in regulating body weight and body fat. Collectively, the present study provides new insights into the regulation of energy homeostasis originating from brush cells and taste cells in the GI tract and signaling to peripheral tissues including the adrenal glands, via the brain.

2. Material and Methods {#s0010}
=======================

2.1. Experimental Animals {#s0015}
-------------------------

All animal experiments were approved by the Animal Care and Use Committee at The University of Tokyo. *Skn-1*/*Pou2f3*-deficient mice with a mixed 129 × C57BL/6J background were generated as previously described ([@bb0140]) and then backcrossed to C57BL/6J for \> 10 generations. Male *Skn-1* KO mice and their WT littermates generated by crossing the heterozygous mice were used in the present study. Mice were fed a normal chow diet (Lab MR Breeder, Nosan Co., Yokohama, Japan) after weaning or High-Fat Diet 32 (CREA Japan Inc., Tokyo, Japan) from 4 weeks of age for \> 12 weeks to induce dietary obesity. Mice were maintained in a room with a constant temperature of 22 ± 1 °C under a 12-h light-dark cycle (lights on at 8 a.m.). Tissue samples were collected from 12- to 16-week-old mice that were fasted for 18 h.

2.2. X-ray Computed Tomography (CT) Scan Analysis {#s0020}
-------------------------------------------------

Mice older than 16 weeks were anesthetized using an isoflurane nebulizer (Muromachi Kikai Co. Ltd., Tokyo, Japan); a Latheta LCT-200 CT instrument (Aloka-Hitachi LCT-200, Tokyo, Japan) was then used to scan abdominal fat and muscle mass and extract thighbone density.

2.3. Blood Chemical Parameters {#s0025}
------------------------------

Blood was collected from approximately 20-week-old mice by cardiac puncture at 10 a.m. under ad libitum feeding condition and after 18-h fasting. Serum chemical parameters and hormones (PTH, T3, and T4) were analyzed by Nagahama Life Science Laboratory (Shiga, Japan). Plasma insulin and leptin were measured using the Luminex 200™ System (Luminex, Austin, TX, USA) by GeneticLab Co., Ltd. (Sapporo, Japan). Plasma adiponectin and FGF21 were measured using mouse adiponectin ELISA (BioVender, Brno, Czech Republic) and mouse and rat FGF-21 ELISA (BioVender), respectively.

2.4. Indirect Calorimetry {#s0030}
-------------------------

Indirect calorimetry was performed on 20- to 28-week-old mice using an indirect calorimeter (ARCO-2000, Arco Systems Inc., Chiba, Japan) and spontaneous motor activity was measured using a pyroelectric infrared ray sensor (NS-AS01, Neuroscience Inc., Tokyo, Japan) for 3--4 days after 2 days of habituation essentially as described by [@bb0225] or with an indirect calorimeter (MK-5000RQ, Muromachi Kikai Co. Ltd.) as previously described ([@bb0250]). The respiratory exchange ratio (RER) was calculated as the molar ratio of VCO~2~/VO~2~. Energy expenditure (kcal per hour) was calculated as heat (kcal/h) = (3.815 + 1.232 × RER) × VO~2~.

2.5. Mitochondrial DNA Copy Number {#s0035}
----------------------------------

To measure the mitochondrial DNA copy number, the ratio of mitochondrial DNA to genomic DNA was calculated by a previously described method ([@bb0250]). In brief, total DNA was extracted from the gastrocnemius of 14- to 19-week-old mice that were fasted for 16 h using a QIAamp DNA mini kit (QIAGEN Ltd., Tokyo, Japan) and used for qPCR (Applied Biosystems Japan Ltd., Tokyo, Japan). We used the TaqMan Gene Expression Assay (Applied Biosystems Foster City, USA; ACTB, Mm00607939_s1; CYTB, Mm044225274). The PCR cycling conditions were 50 °C for 2 min, 95 °C for 10 min, and 40 cycles of 95 °C for 15 s and 60 °C for 1 min. The mitochondrial DNA copy number is presented relative to nuclear DNA following amplification of the mitochondrial gene region (cytochrome *b* vs. the nuclear endogenous control region, β-actin).

2.6. DNA Microarray {#s0040}
-------------------

DNA microarray analysis using total RNA extracted from the gastrocnemius of 12- to 16-week-old mice that were fasted for 18 h was performed as previously described ([@bb0160]) with minor modifications. In brief, Total RNA samples (100 ng each) were prepared and processed for microarray analysis using a 3′ IVT Express kit and GeneChip® Mouse Genome 430 2.0 Array (Affymetrix, Santa Clara, CA, USA) according to the manufacturer\'s standard protocols. The raw microarray data (CEL files) were quantified by the Factor Analysis for Robust Microarray Summarization (FARMS) ([@bb0080]) using the statistical language R ([@bb0220]) and Bioconductor ([@bb0060]). To identify differentially expressed genes, the rank products (RP) method ([@bb0030]) was applied to the FARMS-quantified data. All microarray data are MIAME compliant and have been deposited in a MIAME-compliant database, the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (<http://www.ncbi.nlm.nih.gov/geo/>, GEO Series accession number GSE76936), as described in more detail on the MGED Society web site (<http://www.mged.org/Workgroups/MIAME/miame.html>).

2.7. Fecal TG and Total Energy Content {#s0045}
--------------------------------------

Fecal lipids were extracted from dried feces of 15-week-old mice fed a HFD according to the Folch method ([@bb0050]), and the TG concentration was measured using the Wako triglyceride E-Test (Wako Pure Chemical Industries, Ltd., Osaka, Japan). The total energy content of feces collected for 8 weeks was measured by bomb calorimetry.

2.8. Measurement of Urine Catecholamines {#s0050}
----------------------------------------

Twenty-four-hour urine (for catecholamine measurements) was collected into collection vials from 11- to 12-week-old mice individually housed in metabolic cages. To avoid spontaneous oxidation of catecholamine, 60 μL of hydrochloric acid (6 mol/L) was added to the collection vials ([@bb0150]). The collected urine was purified using MonoSpin PBA (GL Sciences, Tokyo, Japan) and urine catecholamines were measured by HPLC as previously described ([@bb0230]). In brief, Chromatography was performed using an Inertsil ODS-4 column (5 μm, 250 × 20 mm i.d., GL Science) with acetate-citrate buffer at a flow rate of 0.5 mL/min and detected by electrochemical detection. The concentration of urine creatinine was measured using a LabAssay™ Creatinine kit (Wako Pure Chemical Industries, Ltd.).

2.9. qRT-PCR in Adrenal Glands {#s0055}
------------------------------

Total RNA was extracted from adrenal glands using RNeasy mini-columns (Qiagen, Venlo, Netherlands), followed by genomic DNA digestion using RNase-free DNase (Qiagen). First-strand cDNA was generated by reverse transcription from total RNA (Superscript III Reverse Transcription Kit; Life Technologies, Gaithersburg, MD). Levels of mRNA transcripts were determined by qPCR (ABI Prism 7000 Sequence Detection System, Applied Biosystems, Foster City, CA). cDNA levels were normalized against β-actin. PCR amplification was performed using TaqMan technology (TaqMan Gene Expression Assays, Applied Biosystems). The TaqMan probe IDs were as follows: tyrosine hydroxylase (Th; Mm00447557_m1), dopa decarboxylase (Ddc; Mm00516688_m1), dopamine β-hydroxylase (Dbh; Mm00460472_m1), phenylethanolamine *N*-methyltransferase (Pnmt; Mm00476993_m1), and β-actin (Mm00607939_s1). The delta-delta method was used for relative quantification ([@bb0130]).

2.10. OGTT, IPGTT, ITT, and Measurement of Insulin, GIP, and GLP-1 {#s0060}
------------------------------------------------------------------

Gavage administration of glucose (3.0 mg/g of body weight for measurement of blood glucose, plasma insulin, and plasma total GIP; 5.0 mg/g of body weight for measurement of plasma active GLP-1; 2.0 mg/g of body weight for measurement of blood glucose and plasma insulin in mice fed a HFD) was performed on 16-week-old WT and *Skn-1* KO mice at 10 a.m. after 18-h fasting (n = 20--30 animals per group) using a syringe attached to a feeding needle (KN-349-M1, Natsume Seisakusho Co. Ltd., Tokyo, Japan) inserted through the mouth into the stomach. For IPGTT or ITT, mice were fasted for 18 or 4 h, then injected intraperitoneally with glucose (1.5 mg/g of body weight) or insulin (0.75 mU/g of body weight), respectively. Tail blood samples were collected from the tail vein before gavage (time 0) and 15, 30, 45, 60, 90, and 120 min after gavage. For measurement of GIP and GLP-1, tail blood samples were collected into chilled tubes containing DPP-IV Inhibitor (Merck Millipore, Billerica, MA) and/or EDTA and aprotinin (for GLP-1; Wako Pure Chemical Industries, Ltd.) before gavage (time 0) and 15, 30, and 60 min after gavage (for GIP) or 10, 20, and 40 min after gavage (for GLP-1). Blood glucose, plasma insulin, plasma total GIP, and plasma active GLP-1 were measured by Glucose Pilot (Iwai Chemicals Co. Ltd., Tokyo, Japan), Ultra Sensitive Mouse Insulin ELISA Kit (Morinaga Institute of Biological Science Inc., Kanagawa, Japan), Rat/Mouse GIP (Total) ELISA Kit (EZRMGIP-55K, Merck Millipore), and GLP-1 (Active) ELISA Kit (AKMGP-011, Shibayagi Co. Ltd., Gunma, Japan), respectively.

2.11. RT-PCR {#s0065}
------------

First-strand cDNAs from 11 different tissues except the circumvallate papillae (Genostaff, Tokyo, Japan) were used for RT-PCR. For the circumvallate papillae, total RNA was extracted and reverse-transcribed into cDNA with an oligo dT primer. Approximately 500 bp of coding region encompassing multiple exons of Skn-1a was amplified from each cDNA for 30 cycles at an annealing temperature of 60 °C. The volume of PCR products for Skn-1a loaded on the agarose gel was approximately normalized using the PCR product for GAPDH.

2.12. Islet Isolation and In Vitro Insulin Release From Mouse Islets {#s0070}
--------------------------------------------------------------------

Isolated pancreatic islets were prepared by liberase (Roche Diagnostics, Basel, Switzerland) digestion, manually selected, and incubated in RPMI 1640 tissue culture medium (Life Technologies) supplemented with 10% (vol/vol) fetal bovine serum at 37 °C overnight. Insulin secretion in vitro was measured in static incubations. Prior to experiments, islets were pre-incubated for 60 min at 37 °C in Krebs-Ringer (KR) buffer composed of 119 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl~2~, 1.2 mM MgCl~2~, 1.2 mM KH~2~PO~4~, 25 mM NaHCO~3~, and 10 mM HEPES (pH 7.4) with 5% bovine serum albumin. The medium was gassed with 95% O~2~ and 5% CO~2~ to obtain constant pH and oxygenation. The groups of 10 islets were incubated for 60 min at 37 °C in Krebs-Ringer buffer solution containing 2.5 mM glucose (low glucose). The islets were transferred to new low glucose Krebs-Ringer buffer and incubated for 60 min. Subsequently, the islets were incubated in Krebs-Ringer buffer containing 25 mM glucose (high glucose) for 30 min. The supernatants from the second low-glucose solution and from the high-glucose solution were collected for the insulin ELISA assay and stored at − 80 °C. Insulin concentrations were measured using an Ultra Sensitive Mouse Insulin ELISA Kit (Morinaga Institute of Biological Science).

2.13. Immunohistochemistry {#s0075}
--------------------------

Rabbits were immunized with peptides corresponding to residues 1140--1153 (C + PASARDREYLESGL) of Trpm5 (Operon Biotechnologies, Tokyo, Japan). Preincubation of the antibody with peptide antigen (10 ng/mL) abolished the brush cell staining, confirming the specificity of the antibody (data not shown). The other primary antibodies used were as follows: rabbit anti-Skn-1a antibody (\#sc-330, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-Dclk1 antibody (\#AP7219b, Abgent, San Diego, CA), rabbit anti-ChgA antibody (\#20085, ImmunoStar, Hudson, WI), and goat anti-GLP-1 antibody (\#sc-7782, Santa Cruz Biotechnology). Immunohistochemistry was performed as previously described ([@bb0090]). In brief, fresh-frozen sections (10-μm thick) were fixed in 4% paraformaldehyde (PFA), permeabilized with ice-cold methanol, blocked with phosphate-buffered saline (PBS) containing 5% skim milk, and incubated with rabbit anti-Skn-1a antibody (1/1000 dilution), rabbit anti-Trpm5 antibody (1/200 dilution), rabbit anti-Dclk1 antibody (1/50 dilution), or rabbit anti-ChgA antibody (1/200 dilution), followed by incubation with Alexa Fluor 488- (\#A21206) or Alexa Fluor 555-conjugated anti-rabbit IgG (\#A31572, Life Technologies). For GLP-1, fresh-frozen sections (10-μm thick) were fixed with 4% PFA, blocked with PBS containing 5% normal donkey serum and 0.2% Triton X-100, and incubated with goat anti-GLP-1 antibody (1/150 dilution) followed by incubation with Alexa Fluor 555-conjugated anti-goat IgG (\#A21432, Life Technologies).

For double staining, fresh-frozen sections (10-μm thick) were fixed with 4% PFA and permeabilized with ice-cold methanol followed by antigen retrieval. The sections were then blocked with Tris-buffered saline with 0.05% Tween 20 (TBST) containing 5% skim milk and incubated with rabbit anti-Trpm5 antibody (1/200 dilution), followed by incubation with horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (\#31460, Life Technologies) and subsequent reaction with tyramide signal amplification (TSA)-Alexa Fluor 488 (Life Technologies) as a substrate for peroxidase. After antigen retrieval, the sections were blocked with TBST containing 5% skim milk and incubated with rabbit anti-Skn-1a antibody (1/300 dilution) or rabbit anti-Dclk1 antibody (1/50 dilution), followed by incubation with Cy3-conjugated anti-rabbit IgG (\#711-165-152, Jackson ImmunoResearch, West Grove, PA).

2.14. In Situ Hybridization {#s0080}
---------------------------

In situ hybridization was performed as previously described ([@bb0085]). In brief, fresh-frozen sections (10-μm thick) of the small intestine, including the duodenum, jejunum, and ileum, were placed on MAS-coated glass slides (Matsunami Glass, Osaka, Japan) and fixed in 4% PFA in PBS. Prehybridization (at 58 °C for 1 h), hybridization (at 58 °C, 2 O/N), washing (0.2 × SSC at 58 °C), and development (NBT-BCIP) were performed using a digoxigenin-labeled probe for Trpm5. Stained images were obtained using a fluorescence microscope (BX51, Olympus, Tokyo, Japan) equipped with a cooled CCD digital camera (DP71, Olympus).

2.15. Data Analysis and Statistical Methods {#s0085}
-------------------------------------------

All data are presented as the mean ± SEM. Statistically significant differences were assessed using Student\'s *t*-test.

3. Results {#s0090}
==========

3.1. Brush Cells in the GI Tract Are Abolished in *Skn-1* KO Mice {#s0095}
-----------------------------------------------------------------

We first investigated whether Skn-1a plays important roles in the regulation of cell differentiation in the stomach and small intestine. To examine the mRNA expression of *Skn-1a* in the GI tract, we performed RT-PCR analysis of mRNA from several tissues of WT mice. *Skn-1a* was abundantly expressed in the circumvallate papillae, stomach, duodenum, jejunum, and ileum, but it was absent or only faintly expressed in all other tissues examined, including the pancreas, islets of Langerhans, brain, liver, skeletal muscle, white adipose tissue (WAT), and brown adipose tissue (BAT) ([Fig. 1](#f0005){ref-type="fig"}a). RT-PCR of GAPDH as a control revealed comparable levels in all the tissues other than islets of Langerhans and WAT, in which slightly less intense bands were detected ([Fig. 1](#f0005){ref-type="fig"}a). To examine the tissue distribution of *Skn-1a* in the stomach and intestine at the cellular level, we next performed immunohistochemistry using an anti-Skn-1a antibody. In the stomach, Skn-1a signals were abundantly detected in the corpus beneath the limiting ridge ([Fig. 1](#f0005){ref-type="fig"}b). In the duodenum, jejunum, and ileum, Skn-1a signals were observed in approximately 100 cells per section ([Fig. 1](#f0005){ref-type="fig"}b and data not shown). These results suggest that Skn-1a functions as a transcription factor that regulates cell differentiation in the stomach and intestine as well as in the taste buds, nasal respiratory epithelium, and main olfactory epithelium ([@bb0140], [@bb0170], [@bb0260]).

We next examined the expression of *Trpm5* in the small intestine. In situ hybridization analysis using a probe for *Trpm5* revealed that *Trpm5* signals scattered throughout the small intestine including the duodenum, jejunum, and ileum, of WT mice ([Fig. 1](#f0005){ref-type="fig"}c and data not shown), consistent with the previous reports ([@bb0025]). Intriguingly, no signals of *Trpm5* were observed in *Skn-1* KO mice ([Fig. 1](#f0005){ref-type="fig"}c). Immunohistochemistry using an anti-Trpm5 antibody confirmed the presence of the Trpm5 protein in the duodenum of WT mice but the absence of Trpm5 protein in *Skn-1* KO mice (Fig. S1a).

Doublecortin-like kinase 1 (Dclk1) antibody marks brush cells ([@bb0065], [@bb0070], [@bb0195]). Chromogranin A (ChgA) is a marker for enteroendocrine cells ([@bb0185]). GLP-1 is an incretin, a peptide hormone, secreted from enteroendocrine L cells ([@bb0255]). Signals of Dclk1 were detected in WT mice but not in *Skn-1* KO mice ([Fig. 1](#f0005){ref-type="fig"}d). By contrast, signals of ChgA and GLP-1 were observed in WT and *Skn-1* KO mice (Fig. S1a). Finally, we performed double staining using antibodies against Trpm5 and Skn-1a or Dclk1. Nearly all Trpm5-positive cells were also positive for Skn-1a or Dclk1 ([Figs. 1](#f0005){ref-type="fig"}e and S1b). Taken together, these results demonstrate that brush cells expressing *Trpm5* and *Dclk1* are abolished in *Skn-1* KO mice and that Skn-1a is a crucial transcription factor for generating brush cells in the GI tract.

3.2. Metabolic Phenotypes of *Skn-1* KO Mice Fed a Normal Chow Diet {#s0100}
-------------------------------------------------------------------

To examine the effect of eliminating type II taste cells and brush cells in the GI tract on energy homeostasis, we characterized the metabolic phenotypes of *Skn-1* KO mice. Whereas there was no significant difference in body weight at birth between the *Skn-1* KO and WT littermates (Fig. S2a), *Skn-1* KO mice exhibited lower body weight compared to their WT littermates when weaned at 3 weeks of age ([Figs. 2](#f0010){ref-type="fig"}a and S2a). When fed a normal chow diet, *Skn-1* KO mice exhibited significantly lower body weight than their WT littermates throughout the 13 weeks after weaning ([Fig. 2](#f0010){ref-type="fig"}a). For example, the body weights of the *Skn-1* KO and WT littermates at 16 weeks of age were 27.4 ± 0.5 g and 29.8 ± 0.4 g, respectively. X-ray computed tomography (CT) analysis of body composition revealed that *Skn-1* KO mice had a lower body fat percentage than their WT littermates at approximately 20 weeks of age, whereas there was no significant difference in muscle mass percentage between the two genotypes ([Fig. 2](#f0010){ref-type="fig"}b). Among blood chemical parameters, the concentration of serum total ketone bodies was significantly higher in *Skn-1* KO mice than in their WT littermates under ad libitum feeding and 18-h fasting conditions ([Fig. 2](#f0010){ref-type="fig"}c and d). In addition, some parameters related to lipid metabolism, such as cholesterol and non-esterified fatty acid (NEFA) levels, tended to be higher in *Skn-1* KO mice compared with their WT littermates (Tables S1 and S2). Collectively, these results demonstrate that lipid metabolism, such as lipid degradation and β-oxidation of fatty acids, is accelerated in *Skn-1* KO mice.

Despite the lower body weight and body fat percentage of *Skn-1* KO mice, there was no difference in food intake between the *Skn-1* KO and WT littermates at 8 weeks of age ([Fig. 2](#f0010){ref-type="fig"}e) and in water intake between the two genotypes (data not shown). Analysis of the metabolic rates of the mice revealed that the energy expenditure of *Skn-1* KO mice was higher than that of their WT littermates ([Fig. 2](#f0010){ref-type="fig"}f). By contrast, there were no significant differences in the respiratory exchange ratio (RER) or spontaneous motor activity between the two genotypes (Figs. S2b and S2c). These results demonstrate that increased energy expenditure causes reduced body weight with lower body fat percentage in *Skn-1* KO mice.

Quantitative real-time PCR (qPCR) analysis revealed that the mitochondrial DNA content in the skeletal muscle was significantly higher in *Skn-1* KO mice than in their WT littermates ([Fig. 2](#f0010){ref-type="fig"}g). Moreover, DNA microarray analysis revealed enhanced expression of genes involved in mitochondrial function, such as uncoupling proteins 3 (Ucp3), in *Skn-1* KO mice ([Table 1](#t0005){ref-type="table"}). These results suggest that energy expenditure is increased in the skeletal muscle of *Skn-1* KO mice.

3.3. Metabolic Phenotypes of *Skn-1* KO Mice Fed a HFD {#s0105}
------------------------------------------------------

We next examined the metabolic phenotypes of *Skn-1* KO mice fed a HFD. When fed a HFD for \> 12 weeks after 4 weeks of age, the body weight of *Skn-1* KO mice was dramatically lower than that of their WT littermates ([Fig. 3](#f0015){ref-type="fig"}a). For example, the body weights of *Skn-1* KO and WT littermates at 16 weeks of age were 30.4 ± 0.9 g and 39.5 ± 0.9 g, respectively. CT analysis of body composition and measurement of tissue mass revealed that *Skn-1* KO mice had a lower body fat percentage, including epididymal and perirenal white adipose tissues, than their WT littermates at approximately 20 weeks of age, whereas there were no significant differences in the weight ratios of other tissues, such as muscle, between the two genotypes ([Fig. 3](#f0015){ref-type="fig"}b and c and Table S3).

Although there was no significant difference in food intake between the *Skn-1* KO and WT littermates at 8 weeks of age ([Fig. 3](#f0015){ref-type="fig"}d), energy expenditure was higher in *Skn-1* KO mice than in their WT littermates, but spontaneous motor activity was similar between the two genotypes ([Fig. 3](#f0015){ref-type="fig"}e and data not shown). In addition, we observed no differences in food intake or fecal triacylglycerol (TG) between the *Skn-1* KO and WT littermates at 15 weeks of age (Figs. S3a and S3b). Fecal energy content was also comparable between the *Skn-1* KO and WT littermates (Fig. S3c). These results suggest that increased energy expenditure is the primary cause of reduced adiposity in *Skn-1* KO mice fed a HFD.

Finally, we measured plasma adiponectin, FGF21, insulin, and leptin in *Skn-1* KO and WT littermates fed a HFD (Table S4). Plasma leptin tended to be lower in *Skn-1* KO mice compared with their WT littermates (p = 0.08).

3.4. Catecholamine Secretion is Augmented in *Skn-1* KO Mice Fed a HFD {#s0110}
----------------------------------------------------------------------

We examined whether the levels of thyroid hormones, including triiodothyronine (T3), tetraiodothyronine (T4), and thyroid stimulating hormone (TSH), and catecholamines, including norepinephrine, epinephrine, and dopamine, were altered in *Skn-1* KO mice fed a HFD. Serum T3, T4, and TSH were comparable between *Skn-1* KO and WT littermates ([Fig. 4](#f0020){ref-type="fig"}a). We next measured 24-h urinary excretion of catecholamines. Urinary epinephrine and dopamine were significantly higher and norepinephrine tended to be higher (p = 0.06) in *Skn-1* KO mice compared to their WT littermates ([Fig. 4](#f0020){ref-type="fig"}b). qPCR analysis revealed that the gene expression of catecholamine biosynthetic enzymes, including tyrosine hydroxylase (Th), dopa decarboxylase (Ddc), dopamine-β-hydroxylase (Dbh), and phenylethanolamine *N*-methyltransferase (Pnmt), in adrenal glands was comparable between *Skn-1* KO and their WT littermates (Fig. S4). These results suggest that catecholamines are over-secreted from adrenal glands in *Skn-1* KO mice.

3.5. Insulin Secretion is Reduced in *Skn-1* KO Mice {#s0115}
----------------------------------------------------

To examine carbohydrate metabolism in *Skn-1* KO mice, we performed an oral glucose tolerance test (OGTT). Blood glucose concentrations in *Skn-1* KO and WT littermates were comparable for 120 min after oral glucose administration ([Fig. 5](#f0025){ref-type="fig"}a). By contrast, the increase in plasma insulin 60 min after glucose administration was smaller in *Skn-1* KO mice than in their WT littermates ([Fig. 5](#f0025){ref-type="fig"}b). However, plasma GIP and GLP-1, which potentiate insulin secretion from pancreatic β-cells ([@bb0255]), were comparable between *Skn-1* KO and WT littermates after oral glucose administration (Figs. S5a and S5b).

We next examined the insulin secretion ability of pancreatic β-cells in *Skn-1* KO mice. First, RT-PCR analysis revealed that *Skn-1a* was not expressed in the pancreas or islets of Langerhans of WT mice ([Fig. 1](#f0005){ref-type="fig"}a). Second, insulin secretion from isolated islets in response to 25 mM glucose was comparable between *Skn-1* KO and WT littermates (Fig. S5c). Third, in the intraperitoneal glucose tolerance test (IPGTT), blood glucose concentrations were comparable between *Skn-1* KO and WT littermates for 120 min after administration (Fig. S5d). Plasma insulin concentrations were also comparable between *Skn-1* KO and WT littermates before and at 15 min after intraperitoneal administration (Fig. S5e). Collectively, these results demonstrate that insulin secretion from pancreatic β-cells is normal in *Skn-1* KO mice. Finally, the insulin tolerance test (ITT) revealed that *Skn-1* KO and WT littermates had comparable insulin sensitivity (Fig. S5f).

When fed a HFD, blood glucose was significantly lower in *Skn-1* KO mice than their WT littermates for 120 min after oral glucose administration ([Fig. 5](#f0025){ref-type="fig"}c), demonstrating that impaired glucose tolerance in WT littermates fed a HFD is improved in *Skn-1* KO mice. In addition, plasma insulin levels were lower in *Skn-1* KO mice than in their WT littermates before glucose administration (p \< 0.05) and tended to be lower at 15 min after administration (p = 0.10, [Fig. 5](#f0025){ref-type="fig"}d). ITT revealed that the *Skn-1* KO mice had improved insulin resistance compared with their WT littermates ([Fig. 5](#f0025){ref-type="fig"}e). Collectively, these results demonstrate that the insulin resistance and impaired glucose tolerance observed in WT mice fed a HFD are ameliorated in *Skn-1* KO mice.

4. Discussion {#s0120}
=============

In the present study, we demonstrated that brush cells and type II taste cells in the GI tract ([@bb0140]) are unexpectedly abolished in *Skn-1* KO mice. This finding indicates that *Skn-1* is critical for the development of *Trpm5*-expressing chemosensory cells in mice. The *Skn-1* KO mice had reduced body weight with a lower body fat percentage, primarily due to increased energy expenditure. Furthermore, catecholamine secretion was increased in *Skn-1* KO, accompanied by decreased insulin secretion. We propose brain-mediated mechanisms of energy homeostasis originating from brush cells and taste cells in the GI tract to peripheral tissues including the adrenal glands ([Fig. 6](#f0030){ref-type="fig"}). In detail, taste signals and nutrient stimuli, which are sensed by taste cells and brush cells in the GI tract are transmitted to the brain via afferent neurons and/or humoral mediators and subsequently conveyed to adrenal glands that secrete catecholamines via efferent sympathetic nerves. In *Skn-1* KO mice, loss of taste and/or nutrient sensing may intensify the activity of the efferent sympathetic nerves, resulting in exaggerated secretion of catecholamines. Based on the network of the gut-brain axis originating from brush cells and taste cells in the GI tract, the present study suggests an approach to the treatment of obesity.

*Skn-1a* is expressed in *Trpm5*-expressing chemosensory cells. Loss-of-function of *Skn-1a* results in the elimination of these cell types ([@bb0140], [@bb0170], [@bb0260]). In the present study, we demonstrated that *Skn-1a* is expressed in *Trpm5*-expressing brush cells in the GI tract including stomach and intestine. It should be noted that these cells are abolished in the GI tract of *Skn-1* KO mice. Genes encoding sweet taste receptors (T1R2 and T1R3) and downstream signaling molecules such as gustducin are expressed in enteroendocrine L cells that secret GLP-1 ([@bb0095]). When glucose was orally administered, the plasma GLP-1 concentration was not augmented in *gustducin* KO mice compared with WT mice, which resulted in a lack of a rapid increase in plasma insulin levels and an impaired glucose tolerance ([@bb0095]). We showed that GLP-1 signals were similar between WT and *Skn-1* KO mice in immunohistochemical analyses, consistent with normal incretin release after oral glucose administration in *Skn-1* KO mice. These results demonstrate that Skn-1a is also required for the generation of *Trpm5*-expressing brush cells, but not for that of enteroendocrine L cells, in the GI tract.

*Trpm5* is expressed not only in the chemosensory cells but also in the mouse pancreatic β-cell line MIN6, pancreatic islets of Langerhans, and pancreatic β-cells ([@bb0040], [@bb0155], [@bb0175], [@bb0180], [@bb0265]). *Trpm5* plays an important role in the regulation of GSIS from pancreatic β-cells via two major mechanisms: triggering and amplifying pathways ([@bb0035], [@bb0040], [@bb0125]). *Trpm5* KO mice, like *Skn-1* KO mice, gain significantly less body weight and fat mass and are more sensitive to insulin than WT mice when fed either a HFD or a high-carbohydrate diet ([@bb0115]). T1R3 is the common subunit of sweet (T1R2 + T1R3) and umami (T1R1 + T1R3) taste receptors ([@bb0270]). When fed a HFD, *T1R3* KO mice had reduced fat mass, in spite of unaltered body weight ([@bb0205]). *T1R3* is expressed in the gut, pancreas, and adipose tissue as well as in the tongue ([@bb0265]). In contrast, *Skn-1a* was not expressed in the pancreas, islets of Langerhans, or brain, suggesting that the tissue distribution of *Skn-1a* is more restricted than that of *Trpm5* and *T1R3*. In this context, *Skn-1* KO mice are unique models for investigating unexplored mechanisms underlying the gut-brain axis and whole-body energy metabolism.

*Skn-1* KO mice exhibited lower body weight than their WT littermates after weaning when fed either a normal chow diet or a HFD, whereas body weight was indistinguishable between *Skn-1* KO and WT littermates at birth. Notably, the *Skn-1* KO mice had much lower body weight than their WT littermates when fed a HFD; the body weight gain of *Skn-1* KO mice fed a HFD for 12 weeks was nearly equivalent to that of WT mice fed a chow diet during the same period, and the *Skn-1* KO mice did not become obese. In *Skn-1* KO mice fed a HFD, blood glucose levels and insulin secretion as well as insulin tolerance were improved, and plasma leptin, an indicator of body fat mass, tended to be lower than in their WT littermates. These results demonstrate that *Skn-1* KO mice are resistant to HFD-induced metabolic dysregulation.

The reduced body weight of *Skn-1* KO mice was not due to decreased food intake or nutrient absorption but to increased energy consumption, which resulted in a lower body fat ratio. *Skn-1* KO mice exhibited slightly but significantly higher urinary epinephrine and dopamine, implying an increase in the total amounts of these hormones released in 24 h. Because there was no difference in the expression of the biosynthetic enzymes for catecholamine in the adrenal glands, it is unlikely that this significant increase in catecholamine excretion was caused by catecholamine overproduction. Because peripheral secretion of catecholamine is induced by activation of the sympathetic nervous system ([@bb0245]) and *Skn-1a* is not expressed in the brain, it is tempting to speculate that the sympathetic nervous system in *Skn-1* KO mice is activated by unidentified signals from the GI tract to the brain and not alteration of brain function.

In particular, epinephrine and norepinephrine are critical to maintain energy production under hypoglycemia and malnutrition through lipolysis, ketogenesis ([@bb0015], [@bb0210]), and increased mitochondria in skeletal muscle ([@bb0145]). In adipocytes, catecholamines induce lipolysis, but insulin inhibits lipolysis ([@bb0165]). Consistent with previous reports, the copy number of mitochondrial DNA and the concentration of serum total ketone bodies were increased in *Skn-1* KO mice, in accordance with an increase in energy consumption in this model. These results indicate that the appropriate elevation of catecholamine secretion in *Skn-1* KO mice may protect against obesity and metabolic syndrome. Acute psychosocial stress induces changes in catecholamine sensitivity ([@bb0215]). Pheochromocytoma is a tumor arising from adrenomedullary choromaffin cells that automatically overproduce catecholamines ([@bb0120]). Patients with pheochromocytoma with similar levels of circulating catecholamines exhibit variable phenotypes, possibly due in part to differences in hormone sensitivity to the corresponding receptors ([@bb0135]). Catecholamine sensitivity in peripheral tissues may be similarly enhanced by stress signals from the brain in *Skn-1* KO mice.

In the OGTT, *Skn-1* KO mice exhibited a smaller increase in plasma insulin compared with their WT littermates, whereas blood glucose concentrations were indistinguishable between *Skn-1* KO and WT littermates. Why did the *Skn-1* KO mice exhibit such a reduced increase in plasma insulin despite similar changes in blood glucose? First, plasma concentrations of incretins, such as GIP and GLP-1, were comparable between *Skn-1* KO and WT littermates after oral glucose administration, which is consistent with the immunohistochemical analyses revealing that GLP-1 signals were similar between WT and *Skn-1* KO mice. Second, insulin secretion from pancreatic β-cells was normal in *Skn-1* KO mice. Third, *Skn-1* KO and WT littermates showed comparable insulin sensitivity in the ITT. By contrast, urinary epinephrine and dopamine were significantly higher in *Skn-1* KO mice than their WT littermates. Catecholamines inhibit insulin secretion from pancreatic β-cells ([@bb0020]). Overexpression of pancreatic alpha2A-adrenergic receptor in the diabetic Goto-Kakizaki rat mediates adrenergic suppression of insulin secretion ([@bb0190]). Higher catecholamine secretion may inhibit insulin secretion in *Skn-1* KO mice. Collectively, our results demonstrate that enhanced catecholamine secretion in *Skn-1* KO mice induces lipolysis in WAT, accelerates β-oxidation of fatty acids in the liver and skeletal muscle, and, consequently, thermogenesis in skeletal muscle, and inhibits insulin secretion from the pancreas. A range of diverse effects contribute to resistance to HFD-induced obesity and fuel dyshomeostasis ([Fig. 6](#f0030){ref-type="fig"}). Further studies are warranted to elucidate the molecular mechanisms underlying the regulation of energy metabolism originating from brush cells and type II taste cells in the GI tract, e.g., identifying which chemosensory receptors are expressed in the brush cells of the GI tract.

5. Conclusions {#s0125}
==============

In a network of the gut-brain axis, the loss of brush cells and taste cells in the GI tract alters energy metabolism in *Skn-1* KO mice. We thus propose the concept that taste-receiving cells in the oral cavity and/or food-borne chemicals-receiving brush cells in the gut are involved in regulation of the body weight and adiposity. The discovery of food-derived factors that regulate these cells may open new avenues for the treatment of obesity and diabetes.
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![Brush cells are eliminated in the GI tract of *Skn-1* KO mice.\
(a) Tissue distribution of *Skn-1a*. RT-PCR analysis revealed that *Skn-1a* was abundantly expressed in the circumvallate papillae, stomach, duodenum, jejunum, and ileum but absent or only faintly expressed in all other tissues examined, including the pancreas, islets of Langerhans, brain, liver, skeletal muscle, white adipose tissue (WAT), and brown adipose tissue (BAT).\
(b) Immunostaining revealed strong Skn-1a signals in the corpus beneath the limiting ridge in the stomach (upper panel) and in a subset of cells in the small intestine (lower panel). Inset in the upper right corner of each panel shows higher magnification image of the area enclosed by the dashed box.\
(c) In situ hybridization revealed that *Trpm5* mRNA was expressed in the jejunum of WT mice (upper panel) but not in *Skn-1* KO mice (lower panel).\
(d) Immunostaining revealed Dclk1 signals in WT mice (upper panel) but not *Skn-1* KO mice (lower panel). The arrowheads indicate signals.\
(e) Double immunostaining demonstrated that nearly all Trpm5-positive cells were also positive for Skn-1a. The arrows indicate cells expressing Trpm5 and Skn-1a. Scale bars: 100 μm and 25 μm (inset). See also Fig. S1.](gr1){#f0005}

![Metabolic phenotypes of *Skn-1* KO mice fed a normal chow diet.\
(a) Changes in body weight under normal chow diet conditions. When fed a normal chow diet, *Skn-1* KO mice had lower body weight than their WT littermates for 13 weeks after weaning (n \> 75). Also see Fig. S2A.\
(b) *Skn-1* KO mice had a lower body fat percentage than their WT littermates, whereas there was no significant difference in muscle mass percentage between the two genotypes (n = 10--19).\
(c and d) Serum levels of total ketone bodies were higher in *Skn-1* KO mice than their WT littermates under ad libitum feeding (n = 18--28) (c) and 18-h fasting conditions (n = 13) (d).\
(e) *Skn-1* KO and WT littermates had similar food intake at 8 weeks of age (n = 5--8).\
(f) *Skn-1* KO mice exhibited increased energy expenditure compared with their WT littermates (n = 9).\
(g) qRT-PCR analysis revealed that the mitochondrial DNA content in skeletal muscle was significantly higher in *Skn-1* KO mice than in their WT littermates. The data are presented as the mean ± SEM; \*\*p \< 0.01 and \*p \< 0.05. See also Fig. S2.](gr2){#f0010}

![Metabolic phenotypes of *Skn-1* KO mice fed a HFD.\
(a) Changes in body weight under HFD conditions. When fed a HFD for 12 weeks after 4 weeks of age, *Skn-1* KO mice exhibited dramatically reduced body weight compared with their WT littermates (n \> 54).\
(b) *Skn-1* KO mice had a lower body fat percentage than their WT littermates, whereas there were no significant differences in muscle mass percentage between the two genotypes (n = 18--26).\
(c) *Skn-1* KO mice had lower tissue weights of epididymal and perirenal WAT (n = 6--12).\
(d) *Skn-1* KO and WT littermates had similar food intake at 8 weeks of age (n = 8--10).\
(e) *Skn-1* KO mice exhibited increased energy expenditure compared with their WT littermates (n = 4). The data are presented as the mean ± SEM; \*\*p \< 0.01 and \*p \< 0.05. See also Fig. S3.](gr3){#f0015}

![Enhanced catecholamine secretion in *Skn-1* KO mice fed a HFD.\
(a) Serum triiodothyronine (T3), tetraiodothyronine (T4), and thyroid stimulating hormone (TSH) were comparable between *Skn-1* KO and WT littermates (n = 7--8).\
(b) Urinary epinephrine and dopamine were higher in *Skn-1* KO mice than their WT littermates (n = 13--14). The data are presented as the mean ± SEM; \*p \< 0.05. See also Fig. S4.](gr4){#f0020}

![Reduced insulin secretion and improved glucose tolerance and insulin resistance in *Skn-1* KO mice.\
(a and b) Blood glucose (a) and plasma insulin (b) after glucose gavage (3.0 mg/g of body weight) when fed a normal chow diet. Blood glucose was comparable between *Skn-1* KO and WT littermates for 120 min after administration (n = 21--33) (a). *Skn-1* KO mice exhibited a smaller increase in plasma insulin for 60 min after administration compared with their WT littermates (n = 20--21) (b).\
(c and d) Blood glucose (c) and plasma insulin (d) after glucose gavage (2.0 mg/g of body weight) of mice fed a HFD. Blood glucose was lower in *Skn-1* KO mice than their WT littermates for 120 min after administration (n = 26--30) (c). Plasma insulin was lower in *Skn-1* KO mice than their WT littermates before glucose administration (p \< 0.05) and tended to be lower at 15 min after administration (p = 0.10) (n = 25--30) (d).\
(e) Blood glucose after intraperitoneal administration of insulin (0.75 mU/g of body weight) when fed a HFD. *Skn-1* KO mice exhibited improved insulin resistance compared with WT littermates (n = 5). The data are presented as the mean ± SEM; \*\*p \< 0.01 and \*p \< 0.05. See also Fig. S5.](gr5){#f0025}

![Schematic representation of the presumed metabolic pathways originating from brush cells and type II taste cells in the GI tract.\
Food components and digested nutrients are detected by the tongue and GI tract. In *Skn-1* KO mice, the lack of type II taste cells and brush cells results in increased catecholamine secretion. Lipolysis in WAT, serum levels of total ketone bodies, and thermogenesis in muscle are increased, whereas insulin secretion from the pancreas is reduced. Consequently, *Skn-1* KO mice have reduced body weight with lower body fat percentage due to higher energy expenditure.](gr6){#f0030}

###### 

Up-regulated genes related to mitochondrial function in skeletal muscle.

Table 1

  Gene symbol     Gene name                                                                                 Probe ID
  --------------- ----------------------------------------------------------------------------------------- ------------------------------------------------
  ABCD2           ATP-binding cassette, sub-family D (ALD), member 2                                        1419748_at
  Ociad2          OCIA domain containing 2                                                                  1435917_at
  Pptc7           PTC7 protein phosphatase homolog (*S. cerevisiae*)                                        1455958_s\_at
  4930402E16Rik   RIKEN cDNA4930402E16Rik gene                                                              1459869_x\_at
  8430408G22Rik   RIKEN cDNA 8430408G22 gene                                                                1433837_at
  Tbc1d15         TBC1 domain family, member 15                                                             1416062_at
  Xaf1            XIAP associated factor 1                                                                  1443698_at
  Col4a3bp        Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein                          1420384_at
  Dsp             Desmoplakin                                                                               1435493_at, 1435494_s\_at
  DlaT            Dihydrolipoamide *S*-acetyltransferase (E2 component of pyruvate dehydrogenase complex)   1426264_at, 1426265_x\_at
  Fdx1            Ferredoxin 1                                                                              1449108_at
  Gpam            Glycerol-3-phosphate acyltransferase, mitochondrial                                       1419499_at
  Hk2             Hexokinase 2                                                                              1422612_at
  Coq10b          Coenzyme Q10 homolog B (*S. cerevisiae*)                                                  1460510_a\_at
  Immt            Inner membrane protein, mitochondrial                                                     1429533_at
  Ide             Insulin degrading enzyme                                                                  1423121_at, 1435140_at
  Krt5            Keratin 5                                                                                 1424096_at
  Kif1b           Kinesin family member 1B                                                                  1423995_at, 1451642_at, 1451200_at, 1425270_at
  Elovl6          ELOVL family member 6, elongation of long chain fatty acids (yeast)                       1417403_at
  Csde1           Cold shock domain containing E1, RNA binding                                              1423997_at
  Prkca           Protein kinase C, alpha                                                                   1437393_at, 1446598_at, 1450945_at
  Ppm1k           Protein phosphatase 1K (PP2C domain containing)                                           1441988_at
  Ppp3ca          Protein phosphatase 3, catalytic subunit, alpha isoform                                   1426401_at, 1438478_a\_at
  Reep1           Receptor accessory protein 1                                                              1433509_s\_at
  ND5             NADH dehydrogenase subunit 5                                                              1426088_at
  Opa1            Optic atrophy 1                                                                           1434890_at
  Slc25a12        Solute carrier family 25 (mitochondrial carrier, Aralar), member 12                       1436440_at
  Slc25a25        Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25            1424735_at, 1447856_x\_at
  Tmtc1           Transmembrane and tetratricopeptide repeat containing 1                                   1435261_at
  Tap1            Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)                               1416016_at
  Ucp3            Uncoupling protein 3 (mitochondrial, proton carrier)                                      1420658_at
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